Home › Pancreatic Cyst › NCT07767227

Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts

Pilot Proof of Concept Study of miRNA and Protein Signatures in Exosomes From Blood and Cystic Fluid in Patients Undergoing Surgery for Worrisome Pancreatic Cysts

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Voluntarily agree to participate by giving written informed consent prior to any study-specific procedures.
* Subject at least 18 years of age and able to provide consent. Subject is willing and able to comply with requirements of the protocol.
* Radiologically documented cyst of the pancreas for which surgical removal is clinically indicated.
* Patient will be undergoing a surgical resection of their pancreatic cystic neoplasm.

Exclusion Criteria:

* Patient who is pregnant at the time of study enrollment and sample collection.
* Patient will not be undergoing clinically indicated surgery for a pancreatic cystic neoplasm.
* Patient is unwilling or unable to provide informed consent or comply with study procedures.

About the study

The goal of this study is to collect biospecimens (blood and cystic fluid) and data from participants who have a pancreatic cyst that requires surgical resection. The blood and fluid samples will be analyzed for research into DNA, RNA, and proteins.

Sponsor: Translational Genomics Research Institute · Participants: 30 · Started: Feb 3, 2025

Contact the study team

• Michael Demeure, MD · Phone: 949-764-4577

Official record on ClinicalTrials.gov — NCT07767227

Locations in the U.S.

Conditions

• Pancreatic Cyst

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.